Beike Biotechnology’s Shenzhen Facility Earns AABB Accreditation

Beike Biotechnology’s Shenzhen Facility Earns AABB Accreditation

Shenzhen, China – Beike Biotechnology has been granted AABB accreditation for cord blood processing, storage, distribution, cell therapy activity (MSC, cord blood; MSC, placenta; NC, whole blood), somatic cell processing,…

Shenzhen Integrated Cell Bank is Preparing for AABB Accreditation

Shenzhen Integrated Cell Bank is Preparing for AABB Accreditation

In January of 2017 Beike Biotechnology held a meeting with local officials and the international accreditation center to prepare the Shenzhen Integrated Cell Bank for American Association of Blood Bank…

Karolinska Institute of Sweden Discuss Cooperation with Beike’s Shenzhen Cell Bank and Regional Cell Preparation Center

Karolinska Institute of Sweden Discuss Cooperation with Beike’s Shenzhen Cell Bank and Regional Cell Preparation Center

Oct 18, 2016 – A delegation from Sweden’s Karolinska Institute led by Professor Maria Masucci, vice president of international affairs, visited Beike Biotechnology’s headquarters and the International Stem Cell Base…

Specifications for Establishment and Management of Cellular Therapy Product Manufacturing Facility (SZDB/Z 188-2016)’ is Published Officially

Specifications for Establishment and Management of Cellular Therapy Product Manufacturing Facility (SZDB/Z 188-2016)’ is Published Officially

On Jun 22nd, Market Supervision Administration of Shenzhen Municipality had official approval of publication of ‘Specifications for Establishment and Management of Cellular Therapy Product Manufacturing Facility (SZDB/Z 188-2016)’ and formal…

Stem Cell Treatment for Muscular Dystrophy: A New Hope for Refractory Disease in Humans

Stem Cell Treatment for Muscular Dystrophy: A New Hope for Refractory Disease in Humans

Most “normal” people may be more concerned about whether their walking posture is elegant or confident but rarely think how painful and tiresome this simple task is for people with…

Introducing Beike Biotechnology’s Strategic Cooperation and Immunotherapy Programs

Introducing Beike Biotechnology’s Strategic Cooperation and Immunotherapy Programs

Through strategic licensing, acquisition and independent R&D, Beike Biotechnology has gained a strategic position in the immunotherapy field. Beike has multiple international cutting-edge and innovative immunotherapy technologies and products becoming…


1 2 8 9